MEDIORG — Medicamen Organics Income Statement
0.000.00%
Last trade - 00:00- IN₹351.59m
- IN₹460.17m
- IN₹252.72m
Annual income statement for Medicamen Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 250 | 210 | 221 | 253 |
| Cost of Revenue | ||||
| Gross Profit | 82.7 | 68.5 | 79.5 | 106 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Total Operating Expenses | 242 | 206 | 211 | 213 |
| Operating Profit | 8.17 | 3.52 | 10.3 | 40.2 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 3.93 | 1.29 | 12.8 | 33.9 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 2.44 | 0.783 | 12.5 | 24 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 2.44 | 0.783 | 12.5 | 24 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 2.44 | 0.783 | 12.5 | 24 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.209 | 0.067 | 1.07 | 2.05 |